The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.
about
Treating Negative Symptoms in Schizophrenia: an UpdateMice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
P2860
The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The benefit of minocycline on ...... a randomised controlled trial.
@ast
The benefit of minocycline on ...... a randomised controlled trial.
@en
type
label
The benefit of minocycline on ...... a randomised controlled trial.
@ast
The benefit of minocycline on ...... a randomised controlled trial.
@en
prefLabel
The benefit of minocycline on ...... a randomised controlled trial.
@ast
The benefit of minocycline on ...... a randomised controlled trial.
@en
P2093
P2860
P50
P1433
P1476
The benefit of minocycline on ...... a randomised controlled trial.
@en
P2093
Danuta M Lisiecka
Eileen M Joyce
Imran B Chaudhry
Thomas R E Barnes
P2860
P2888
P356
10.1186/S13063-015-0580-X
P407
P577
2015-03-02T00:00:00Z
P5875
P6179
1040231775